Cookie Disclaimer

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you`re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. Cookie settings

TAG overview

Results

(3) Discretionary decisions and sources of estimation uncertainty

General Disclosures

(3) Discretionary decisions and sources of estimation uncertainty

Dealing with discretionary decisions and sources of estimation uncertainty

The preparation of the consolidated financial statements requires the Group to make discretionary decisions and assumptions as well as estimates to a certain extent. The discretionary scope and estimation uncertainty are assessed in a Group-specific manner. Discretion describes the need to make assumptions concerning recognition or measurement. Estimation uncertainty denotes the degree of availability and reliability of historical experience and external data for future developments.

Increased uncertainty due to the Covid-19 pandemic

The Group is continuously examining the impact of the Covid-19 pandemic on its business and the resulting effects for the Group’s accounting. To date, the Fertility franchise in the Healthcare business sector and the Surface Solutions and Display Solutions business units in the Performance Materials business sector have been most negatively affected by the Covid-19 pandemic. By contrast, the Process Solutions business unit in the Life Science business sector in particular is benefiting from increased demand, while all the other areas have seen either a slight negative impact or been largely unaffected by the pandemic. Based on the course of business and current planning, there was nothing to suggest that the going concern assumption should not have been applied in preparing these consolidated financial statements. As a preventive measure, however, the Group had increased its cash and cash equivalents in order to secure its liquidity in the meantime. There was no risk of a liquidity bottleneck at any time. Due to the high dynamics of the pandemic and the lack of historical experience, the estimates in these consolidated financial statements are subject to a greater degree of uncertainty than would usually be the case. Where making estimates involved particular challenges as a result of the Covid-19 pandemic, this is discussed in the following overview and the respective notes.

Overview of significant discretionary decisions and sources of estimation uncertainty

The accounting matters with the most significant discretionary decisions as well as the most comprehensive assumptions relating to the future and sources of estimation uncertainty are described below:

Accounting matter

 

Carrying amount as of Dec. 31, 2020 in € million

 

IFRS

 

Discretionary scope/ estimation uncertainty

 

Sensitivity analysis

 

Increased uncertainty due to the Covid-19 pandemic

 

Note

Goodwill

 

15,959

 

 

 

 

 

yes

 

yes

 

18

Determination of recoverable amount

 

 

 

IAS 36

 

high

 

 

 

 

 

 

Other intangible assets

 

7,653

 

 

 

 

 

yes

 

yes

 

6, 19

Identification and measurement of intangible assets within the scope of business combinations

 

 

 

IFRS 3

 

high

 

 

 

 

 

 

In-licensing of intangible assets

 

 

IAS 38

 

medium

 

 

 

 

Determination of amortization

 

 

IAS 38

 

medium

 

 

 

 

Identification of impairments or reversal of impairments

 

 

IAS 36

 

high

 

 

 

 

Property, plant, and equipment

 

6,421

 

 

 

 

 

no

 

no

 

20

Determination of depreciation

 

 

 

IAS 16

 

medium

 

 

 

 

 

 

Identification of impairments or reversal of impairments

 

 

IAS 36

 

medium

 

 

 

 

Leases

 

429

 

 

 

 

 

yes

 

no

 

21

Recognition and measurement of lease arrangements

 

 

 

IFRS 16

 

medium

 

 

 

 

 

 

Inventories

 

3,294

 

 

 

 

 

no

 

yes

 

24

Identification of impairments or reversal of impairments

 

 

 

IAS 2

 

medium

 

 

 

 

 

 

Trade and other receivables

 

3,221

 

 

 

 

 

yes

 

yes

 

25, 42

Determination of loss allowance

 

 

 

IFRS 9

 

medium

 

 

 

 

 

 

Other financial assets

 

 

 

 

 

 

yes

 

no

 

36, 43

Determination of fair values of contingent considerations

 

260

 

IFRS 13

 

high

 

 

 

 

 

 

Determination of fair values of equity instruments

 

499

 

IFRS 9, IFRS 13

 

medium

 

 

 

 

Provisions for pensions and other post-employment benefits

 

 

 

 

 

 

 

yes

 

yes

 

33

Determination of parameters for the valuation of present value of defined-benefit obligations

 

6,352

 

IAS 19

 

medium

 

 

 

 

 

 

Other provisions and contingent liabilities

 

741

 

 

 

 

 

no

 

no

 

27, 28, 33

Recognition and measurement of other provisions and contingent liabilities

 

 

 

IAS 37

 

high

 

 

 

 

 

 

Determination of parameters for the valuation of fair values of share-based payment programs

 

 

IFRS 2

 

medium

 

 

 

 

Collaboration agreements

 

 

 

 

 

 

yes

 

no

 

7

Revenue recognition for upfront and milestone payments in collaboration agreements

 

 

-

 

medium

 

 

 

 

 

 

Revenue recognition

 

 

 

 

 

 

yes

 

no

 

9

Measurement of sales deductions and refund liabilities

 

666

 

IFRS 15

 

high

 

 

 

 

 

 

Income tax

 

 

 

 

 

 

 

no

 

no

 

15

Recognition and measurement of income tax liabilities

 

1,460

 

IAS 12

 

high

 

 

 

 

 

 

Recognition and measurement of deferred taxes from temporary differences

 

 

 

IAS 12

 

medium

 

 

 

 

Recognition of deferred tax assets from tax loss carryforwards

 

20

 

IAS 12

 

high

 

 

 

 

Assets held for sale

 

 

 

 

 

 

 

no

 

no

 

6

Date on which assets and liabilities are classified as “held for sale”

 

 

IFRS 5

 

medium